Changes in the serum concentrations of adhesion molecules and vascular endothelial growth factor in active ankylosing spondylitis patients taking amtolmetin guacil: Results of a 56-week prospective ореn-label controlled observational study
Aim. To estimate changes in the concentrations of adhesion molecules and vascular endothelial growth factor A after 30-day additional use of amtolmetin guacil (AMG) in patients with active ankylosing spondylitis (AS) who were unresponsive to previous one-year treatment with nonsteroidal anti-inflamm...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
"Consilium Medicum" Publishing house
2017-05-01
|
| Series: | Терапевтический архив |
| Subjects: | |
| Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/32197/pdf |
| id |
doaj-28bfc7aad1dc4b658a01322857c33ba5 |
|---|---|
| record_format |
Article |
| spelling |
doaj-28bfc7aad1dc4b658a01322857c33ba52020-11-25T03:32:38Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422017-05-01895384510.17116/terarkh201789538-4529197Changes in the serum concentrations of adhesion molecules and vascular endothelial growth factor in active ankylosing spondylitis patients taking amtolmetin guacil: Results of a 56-week prospective ореn-label controlled observational studyI Z GaydukovaE V KhondkaryanA V AparkinaA P RebrovAim. To estimate changes in the concentrations of adhesion molecules and vascular endothelial growth factor A after 30-day additional use of amtolmetin guacil (AMG) in patients with active ankylosing spondylitis (AS) who were unresponsive to previous one-year treatment with nonsteroidal anti-inflammatory drugs (NSAIDs). Subjects and methods. 20 patients with active AS who had not reached a BASDAI scorehttps://ter-arkhiv.ru/0040-3660/article/viewFile/32197/pdfankylosing spondylitisnonsteroidal anti-inflammatory drugsamtolmetin guaciladhesion moleculesvascular endothelial growth factorsendothelial dysfunction |
| collection |
DOAJ |
| language |
Russian |
| format |
Article |
| sources |
DOAJ |
| author |
I Z Gaydukova E V Khondkaryan A V Aparkina A P Rebrov |
| spellingShingle |
I Z Gaydukova E V Khondkaryan A V Aparkina A P Rebrov Changes in the serum concentrations of adhesion molecules and vascular endothelial growth factor in active ankylosing spondylitis patients taking amtolmetin guacil: Results of a 56-week prospective ореn-label controlled observational study Терапевтический архив ankylosing spondylitis nonsteroidal anti-inflammatory drugs amtolmetin guacil adhesion molecules vascular endothelial growth factors endothelial dysfunction |
| author_facet |
I Z Gaydukova E V Khondkaryan A V Aparkina A P Rebrov |
| author_sort |
I Z Gaydukova |
| title |
Changes in the serum concentrations of adhesion molecules and vascular endothelial growth factor in active ankylosing spondylitis patients taking amtolmetin guacil: Results of a 56-week prospective ореn-label controlled observational study |
| title_short |
Changes in the serum concentrations of adhesion molecules and vascular endothelial growth factor in active ankylosing spondylitis patients taking amtolmetin guacil: Results of a 56-week prospective ореn-label controlled observational study |
| title_full |
Changes in the serum concentrations of adhesion molecules and vascular endothelial growth factor in active ankylosing spondylitis patients taking amtolmetin guacil: Results of a 56-week prospective ореn-label controlled observational study |
| title_fullStr |
Changes in the serum concentrations of adhesion molecules and vascular endothelial growth factor in active ankylosing spondylitis patients taking amtolmetin guacil: Results of a 56-week prospective ореn-label controlled observational study |
| title_full_unstemmed |
Changes in the serum concentrations of adhesion molecules and vascular endothelial growth factor in active ankylosing spondylitis patients taking amtolmetin guacil: Results of a 56-week prospective ореn-label controlled observational study |
| title_sort |
changes in the serum concentrations of adhesion molecules and vascular endothelial growth factor in active ankylosing spondylitis patients taking amtolmetin guacil: results of a 56-week prospective ореn-label controlled observational study |
| publisher |
"Consilium Medicum" Publishing house |
| series |
Терапевтический архив |
| issn |
0040-3660 2309-5342 |
| publishDate |
2017-05-01 |
| description |
Aim. To estimate changes in the concentrations of adhesion molecules and vascular endothelial growth factor A after 30-day additional use of amtolmetin guacil (AMG) in patients with active ankylosing spondylitis (AS) who were unresponsive to previous one-year treatment with nonsteroidal anti-inflammatory drugs (NSAIDs). Subjects and methods. 20 patients with active AS who had not reached a BASDAI score |
| topic |
ankylosing spondylitis nonsteroidal anti-inflammatory drugs amtolmetin guacil adhesion molecules vascular endothelial growth factors endothelial dysfunction |
| url |
https://ter-arkhiv.ru/0040-3660/article/viewFile/32197/pdf |
| work_keys_str_mv |
AT izgaydukova changesintheserumconcentrationsofadhesionmoleculesandvascularendothelialgrowthfactorinactiveankylosingspondylitispatientstakingamtolmetinguacilresultsofa56weekprospectiveorenlabelcontrolledobservationalstudy AT evkhondkaryan changesintheserumconcentrationsofadhesionmoleculesandvascularendothelialgrowthfactorinactiveankylosingspondylitispatientstakingamtolmetinguacilresultsofa56weekprospectiveorenlabelcontrolledobservationalstudy AT avaparkina changesintheserumconcentrationsofadhesionmoleculesandvascularendothelialgrowthfactorinactiveankylosingspondylitispatientstakingamtolmetinguacilresultsofa56weekprospectiveorenlabelcontrolledobservationalstudy AT aprebrov changesintheserumconcentrationsofadhesionmoleculesandvascularendothelialgrowthfactorinactiveankylosingspondylitispatientstakingamtolmetinguacilresultsofa56weekprospectiveorenlabelcontrolledobservationalstudy |
| _version_ |
1724567077136629760 |